Jamie N.Ward

Associate

Chicago + 1.312.269.4098

Jamie Ward represents clients in a variety of complex commercial litigation matters in federal and state courts. Jamie has diverse litigation experience including briefing and motions practice, offensive and defensive discovery, taking and defending depositions, and the evaluation, development, and preparation of fact and expert witnesses.

Jamie's recent experience includes representing Experian, one of the three national credit reporting agencies in the United States, in consumer litigation under the federal Fair Credit Reporting Act. Her practice also includes False Claims Act qui tam litigation and professional negligence litigation on behalf of one of the country's leading diagnostic laboratories.

Jamie maintains an active pro bono practice, including representing habeas petitioners in federal district and appellate courts and representing refugees seeking asylum both in immigration court and before the Board of Immigration Appeals. She also serves as a member of the Chicago Public Library Foundation's Associate Board.

Experience

  • Fortune 40 company defends against FCA claims by former contractorJones Day represented a Fortune 40 company in defense of federal and state False Claims Act claims asserted by a former contractor in connection with a public works technology contract funded by Department of Homeland Security.
  • BioMarin resolves patent infringement claims against Par Pharmaceutical related to Kuvan®Jones Day client BioMarin Pharmaceutical, Inc. successfully resolved a patent infringement action against Par Pharmaceutical, Inc. relating to the defendant's submission of an Abbreviated New Drug Application to the FDA seeking approval of a generic version of Kuvan® (sapropterin dihydrocholride), the only FDA-approved treatment to reduce blood phenylalanine levels in persons with BH-4 responsive phenylketonuria (PKU).
  • Jones Day, working with Lawyers’ Committee for Better Housing, obtains favorable settlement for client facing evictionThe Firm represented a client referred by Lawyers’ Committee for Better Housing whose landlord sought to evict her from her apartment.
  • BioMarin asserts patent infringement claims against Dr. Reddy's Laboratories related to Kuvan®Jones Day represented BioMarin Pharmaceutical, Inc. in a patent infringement action against Dr. Reddy's Laboratories relating to the defendant's submission of an Abbreviated New Drug Application to the FDA seeking approval of a generic versions of Kuvan® (sapropterin dihydrocholride), the only FDA-approved treatment to reduce blood phenylalanine levels in persons with BH-4 responsive phenylketonuria (PKU).
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.